Literature DB >> 32116018

Gene knockout of the Na+-glucose cotransporter SGLT2 in a murine model of acute kidney injury induced by ischemia-reperfusion.

Josselin Nespoux1, Rohit Patel1, Haiyan Zhang2, Winnie Huang1, Brent Freeman1, Paul W Sanders3, Young Chul Kim1, Volker Vallon1,4.   

Abstract

In the early proximal tubule, Na+-glucose cotransporter 2 (SGLT2) mediates the bulk of renal glucose reabsorption. Gene deletion in mice (Sglt2-/-) was used to determine the role of SGLT2 in acute kidney injury induced by bilateral ischemia-reperfusion (IR). In Sglt2-/- and littermate wild-type mice, plasma creatinine increased similarly on day 1 after IR. This was associated with an equal increase in both genotypes in the urinary kidney injury molecule-1-to-creatinine ratio, a tubular injury marker, and similarly reduced urine osmolality and increased plasma osmolality, indicating impaired urine concentration. In both IR groups, FITC-sinistrin glomerular filtration rate was equally reduced on day 14, and plasma creatinine was similarly and incompletely restored on day 23. In Sglt2-/- mice subjected to IR, fractional urinary glucose excretion was increased on day 1 but reduced and associated with normal renal Na+-glucose cotransporter 1 (Sglt1) mRNA expression on day 23, suggesting temporary SGLT1 suppression. In wild-type mice subjected to IR, renal Sglt1 mRNA was likewise normal on day 23, whereas Sglt2 mRNA was reduced by 57%. In both genotypes, IR equally reduced urine osmolality and renal mRNA expression of the Na+-K+-2Cl- cotransporter and renin on day 23, suggesting thick ascending limb dysfunction, and similarly increased renal mRNA expression of markers of injury, inflammation, oxidative stress, and fibrosis (kidney injury molecule-1, neutrophil gelatinase-associated lipocalin, monocyte chemoattractant protein-1, transforming growth factor-β1, NADPH oxidase-2, and collagen type 1). This was associated with equal increases in kidney histological damage scores and similar degree of capillary loss in both genotypes. The data indicate that genetic deletion of SGLT2 did not protect the kidneys in the initial injury phase or the subsequent recovery phase in a mouse model of IR-induced acute kidney injury.

Entities:  

Keywords:  Na+-glucose cotransporter 2; acute kidney injury; sodium-glucose cotransport

Mesh:

Substances:

Year:  2020        PMID: 32116018      PMCID: PMC7294332          DOI: 10.1152/ajprenal.00607.2019

Source DB:  PubMed          Journal:  Am J Physiol Renal Physiol        ISSN: 1522-1466


  50 in total

Review 1.  Targeting renal glucose reabsorption to treat hyperglycaemia: the pleiotropic effects of SGLT2 inhibition.

Authors:  Volker Vallon; Scott C Thomson
Journal:  Diabetologia       Date:  2016-11-22       Impact factor: 10.122

2.  Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes.

Authors:  Stephen D Wiviott; Itamar Raz; Marc P Bonaca; Ofri Mosenzon; Eri T Kato; Avivit Cahn; Michael G Silverman; Thomas A Zelniker; Julia F Kuder; Sabina A Murphy; Deepak L Bhatt; Lawrence A Leiter; Darren K McGuire; John P H Wilding; Christian T Ruff; Ingrid A M Gause-Nilsson; Martin Fredriksson; Peter A Johansson; Anna-Maria Langkilde; Marc S Sabatine
Journal:  N Engl J Med       Date:  2018-11-10       Impact factor: 91.245

3.  The link between acute kidney injury and chronic kidney disease.

Authors:  Linda Y Belayev; Paul M Palevsky
Journal:  Curr Opin Nephrol Hypertens       Date:  2014-03       Impact factor: 2.894

4.  Possible adverse effects of SGLT2 inhibitors on bone.

Authors:  Simeon I Taylor; Jenny E Blau; Kristina I Rother
Journal:  Lancet Diabetes Endocrinol       Date:  2014-12-16       Impact factor: 32.069

Review 5.  PGC1α in the kidney.

Authors:  Matthew R Lynch; Mei T Tran; Samir M Parikh
Journal:  Am J Physiol Renal Physiol       Date:  2017-09-20

6.  Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes.

Authors:  Bruce Neal; Vlado Perkovic; Kenneth W Mahaffey; Dick de Zeeuw; Greg Fulcher; Ngozi Erondu; Wayne Shaw; Gordon Law; Mehul Desai; David R Matthews
Journal:  N Engl J Med       Date:  2017-06-12       Impact factor: 91.245

7.  Gene deletion of the Na+-glucose cotransporter SGLT1 ameliorates kidney recovery in a murine model of acute kidney injury induced by ischemia-reperfusion.

Authors:  Josselin Nespoux; Rohit Patel; Kelly L Hudkins; Winnie Huang; Brent Freeman; Young Chul Kim; Hermann Koepsell; Charles E Alpers; Volker Vallon
Journal:  Am J Physiol Renal Physiol       Date:  2019-04-17

8.  Dapagliflozin, SGLT2 Inhibitor, Attenuates Renal Ischemia-Reperfusion Injury.

Authors:  Yoon-Kyung Chang; Hyunsu Choi; Jin Young Jeong; Ki-Ryang Na; Kang Wook Lee; Beom Jin Lim; Dae Eun Choi
Journal:  PLoS One       Date:  2016-07-08       Impact factor: 3.240

Review 9.  Novel Therapies for Acute Kidney Injury.

Authors:  Huaizhen Chen; Laurence William Busse
Journal:  Kidney Int Rep       Date:  2017-06-28

10.  Capillary rarefaction from the kidney point of view.

Authors:  Baris Afsar; Rengin E Afsar; Tuncay Dagel; Ege Kaya; Suat Erus; Alberto Ortiz; Adrian Covic; Mehmet Kanbay
Journal:  Clin Kidney J       Date:  2017-11-28
View more
  6 in total

Review 1.  Glucose transporters in the kidney in health and disease.

Authors:  Volker Vallon
Journal:  Pflugers Arch       Date:  2020-03-06       Impact factor: 3.657

Review 2.  Effects of SGLT2 Inhibitors on Kidney and Cardiovascular Function.

Authors:  Volker Vallon; Subodh Verma
Journal:  Annu Rev Physiol       Date:  2020-11-16       Impact factor: 19.318

3.  Empagliflozin Enhances Autophagy, Mitochondrial Biogenesis, and Antioxidant Defense and Ameliorates Renal Ischemia/Reperfusion in Nondiabetic Rats.

Authors:  Moein Ala; Mohammad Reza Fallahpour Khoshdel; Ahmad Reza Dehpour
Journal:  Oxid Med Cell Longev       Date:  2022-01-28       Impact factor: 6.543

Review 4.  Glucose Metabolism in Acute Kidney Injury and Kidney Repair.

Authors:  Lu Wen; Ying Li; Siyao Li; Xiaoru Hu; Qingqing Wei; Zheng Dong
Journal:  Front Med (Lausanne)       Date:  2021-11-29

Review 5.  A Role for SGLT-2 Inhibitors in Treating Non-diabetic Chronic Kidney Disease.

Authors:  Lucia Del Vecchio; Angelo Beretta; Carlo Jovane; Silvia Peiti; Simonetta Genovesi
Journal:  Drugs       Date:  2021-08-07       Impact factor: 9.546

Review 6.  Sodium-Glucose Cotransporter-2 Inhibitors in Vascular Biology: Cellular and Molecular Mechanisms.

Authors:  Lei Xiao; Xin Nie; Yanyan Cheng; Nanping Wang
Journal:  Cardiovasc Drugs Ther       Date:  2021-07-17       Impact factor: 3.727

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.